Messe, S., Demopoulos, L., Haws, T., Khonezhad, A., Leshnower, B., Caselli, J., … Bavaria, J. (2016). A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair. In NEUROLOGY (Vol. 86).

Messe, Steven, Laura Demopoulos, Thomas Haws, Ali Khonezhad, Bradley Leshnower, Joseph Caselli, Jehangir Appoo, et al. “A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair.” In NEUROLOGY, Vol. 86, 2016.

Messe S, Demopoulos L, Haws T, Khonezhad A, Leshnower B, Caselli J, et al. A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair. In: NEUROLOGY. 2016.

Messe, Steven, et al. “A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair.” NEUROLOGY, vol. 86, 2016.

Messe S, Demopoulos L, Haws T, Khonezhad A, Leshnower B, Caselli J, Appoo J, Hughes G, Reece T, Brinster D, Kasner S, Kern J, Desai N, Ballard V, Fang F, Lepore J, Bavaria J. A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair. NEUROLOGY. 2016.